Reports Reveal Nearly 50% of Approved Cancer Drugs May be Ineffective
Patient safety and well-being might be getting compromised by bringing ineffective cancer treatments to market.
Patient safety and well-being might be getting compromised by bringing ineffective cancer treatments to market.
With promising results in a clinical trial, new drug rusfertide may effectively treat polycythemia vera.
Researchers share risk factors that could contribute to this deadly form of cancer.
Sweden has the lowest smoking rate of any EU member state, at just 5.6%, just above the official 5% ‘smoke free’ limit used by international bodies, and is on track to become smoke free this year.
The administration plans to invest $15 million in smoking cessation programs targeting menthol and flavored tobacco use.
Researchers have concluded having a mental health diagnosis has no impact on cancer risk.
Vaccines may provide preventive treatment and more effective targeting of existing tumors.
Drugmakers are steering away from generic cancer options.
The higher mortality rates from breast cancer among black women are a significant public health concern that demands attention and action.
Telemedicine consultations and follow-ups are still preferred by most cancer patients.